2-Picolinic Acid

2-Picolinic Acid

SCHEMBL4813302

O=C(O)c1ccccn1.c1ccncc1

nearest known ligand 0.87

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.87
L3MBTL1 Q9Y468 2/20 0.87
NAPRT Q6XQN6 2/20 0.87
P4HTM Q9NXG6 1/20 0.87
CES2 O00748 1/20 0.61
CES1 P23141 1/20 0.61
KMT2A Q03164 4/20 0.59
ALDH1A1 P00352 2/20 0.57
GSK3B P49841 1/20 0.52
KDM4E B2RXH2 4/20 0.50
NPC1 O15118 3/20 0.50
RAB9A P51151 3/20 0.50
MAPT P10636 2/20 0.50
PKM P14618 1/20 0.50
HCAR2 Q8TDS4 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
ACMSD Q8TDX5 1/20 0.48
TDP1 Q9NUW8 1/20 0.48
PTGS2 P35354 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
2-Picolinic Acid SCHEMBL28365061 1.00 LMNA (0.87) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL27883128 0.98 LMNA (0.83) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL29368665 0.93
2-Picolinic Acid SCHEMBL36055 0.93
2-Picolinic Acid SCHEMBL7457912 0.93 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL28737810 0.93 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL674837 0.93 LMNA (1.00) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL6260363 0.92 LMNA (0.80) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL5667302 0.91 LMNA (0.95) LMNAL3MBTL1NAPRTP4HTMCES2
2-Picolinic Acid SCHEMBL1469 0.91 LMNA (0.95) LMNAL3MBTL1NAPRTP4HTMCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117658912-A Methyl lotus alkaloid derivative intermediate and preparation method and application thereof 中南大学湘雅医院 2024-03-08 CN claimed
US-5830867-A Hemoregulatory peptides for stimulating the myelopoietic system SMITHKLINE BEECHAM CORPORATION (US) 1998-11-03 US claimed
US-5545761-A USING OXIDATION CATALYSTS ARISTECH CHEMICAL CORPORATION (US) 1996-08-13 US claimed
CN-117658912-A Methyl lotus alkaloid derivative intermediate and preparation method and application thereof 中南大学湘雅医院 2024-03-08 CN disclosed
CN-115867586-A Electrochemically debondable adhesive compositions 汉高股份有限及两合公司 2023-03-28 CN disclosed
CN-110563662-A Compound and organic electronic device thereof 上海嵘彩光电材料有限公司 2019-12-13 CN disclosed
CN-109403069-A A kind of dyeing of TR looped fabric 绍兴华星丝织印染有限公司 2019-03-01 CN disclosed
CN-108299465-A A kind of drug and preparation method thereof for treating pancreatitis 牡丹江医学院 2018-07-20 CN disclosed
CN-104988531-B The method that a kind of selective dechlorination of chloro-pyridine formic acid electro-catalysis prepares pyridine carboxylic acid 浙江工业大学 2017-11-07 CN disclosed
CN-104988531-A Method for preparing picolinic acid through electro-catalysis selective dechloridation of chloropicolinicacid UNIV ZHEJIANG TECHNOLOGY 2015-10-21 CN disclosed
US-7390904-B2 Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines CIBA SPECIALTY CHEMICALS CORPORATION (US) 2008-06-24 US disclosed
EP-1644329-A1 HYDROGEN PEROXIDE CATALYZED PROCESS FOR THE PREPARATION OF STERICALLY HINDERED N-HYDROCARBYLOXYAMINES Ciba SC Holding AG (CH) 2006-04-12 EP disclosed
US-20050014948-A1 Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines CIBA SPECIALTY CHEMICALS CORP. 2005-01-20 US disclosed
WO-2005005388-A1 HYDROGEN PEROXIDE CATALYZED PROCESS FOR THE PREPARATION OF STERICALLY HINDERED N-HYDROCARBYLOXYAMINES CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2005-01-20 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050014948-A1 Hydrogen peroxide catalyzed process for the preparation of sterically hindered N-hydrocarbyloxyamines HAO2, SOD1, PPOX LMNA 3323/4885L3MBTL1 2577/4885NAPRT 1123/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.